Browse > Article
http://dx.doi.org/10.13048/jkm.14029

A Review on Korean Medicine and Personalized Medicine: Syndrome-based Personalized Medicine on the Basis of Syndrome Differentiation and Treatment  

Han, Jae Min (Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University)
Yang, Woong Mo (Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Medicine / v.35, no.3, 2014 , pp. 40-48 More about this Journal
Abstract
Objectives: This study aimed to review the characteristics of personalized medicine and Korean medicine, and the correlation between personalized medicine and Korean medicine. Methods: We investigated various studies in PubMed, Scopus and domestic Korean medicine journals. In addition, we discussed the topic based on literature. Results: Western medicine developed as evidence-based medicine. However, its limitations are being reached, so a new paradigm of medicine is needed. As a result, personalized medicine has appeared. Recently, through the development of human genomics, personalized medicine has been researched on the basis of individual genetic characteristics. Korean medicine has developed with a unique holistic approach and treats not the disease itself but the patient's body. Its characteristic is well expressed through syndrome differentiation and treatment. Syndrome differentiation represents the nature of person-centered medicine and becomes the root of personalized medicine. Conclusions: Compared with genome-based personalized medicine of Western medicine, Korean medicine could be classified as syndrome-based personalized medicine. It would be great to apply this characteristic to clinical practices.
Keywords
Korean medicine; personalized medicine; tailored care; syndrome differentiation and treatment; syndrome-based personalized medicine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ahn HS. Introduction to Evidence-based Medicine. Journal of Korean Society of Quality Assurance in Health Care. 2005;12(2):9-16.
2 Lim YC. A Critical Contemplation on 'Personalized Medicine' of Modern Medicine. The Korean Association for Philosophy of Medicine. 2012; 13:135-162.
3 Hong KW, Oh B. Overview of personalized medicine in the disease genomic era. BMB Rep. 2010;43(10):643648.
4 Lee SW, Lee KB, Kang JW, Choi JH, Oh JH. Trends in Personalized Medicine Research, Communications of the Korean Institute of Information Scientists and Engineer. 2011;29(4): 19-25.
5 Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, et al. Clinical Pharmacogenetics and Potential Application in Personalized Medicine. Curr Drug Metab. 2008;9(8):738-84.   DOI   ScienceOn
6 Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010; 363(4):301-4.   DOI   ScienceOn
7 Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature. 2009; 461(7265):724-6.   DOI   ScienceOn
8 Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009;10(2): 188-91.   DOI   ScienceOn
9 Dai J, Fang J, Sun S, Chen Q, Cao H, Zheng N, et al. ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine. Evid Based Complement Alternat Med. 2013;2013:235969.
10 Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992; 268(17):2420-5.   DOI   ScienceOn
11 Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996; 312(7023):71-2.   DOI   ScienceOn
12 Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ. 1995;310(6987):1122-6.   DOI   ScienceOn
13 Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-78.   DOI   ScienceOn
14 Gispen WH, Adan RAH. Preface. Eur J Pharmacol. 2000;410(2-3):105.   DOI
15 Shin JG, Cha IJ. Pharmacogenetics: A Principle for the Personalized Pharmacotherapy. Inje Medical Journal. 2002;23(2):71-83.
16 Yan Q. Pharmacogenomics in Drug Discovery and Development : From Bench to Bedside. Clifton:Methods Mol Biol. 2008;448:5-7.
17 Zhang A, Sun H, Wang P, Han Y, Wang X. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement Ther Med. 2012;20(1-2): 93-9.   DOI
18 Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal. 2011;55(5):859-68.   DOI   ScienceOn
19 Kim WH. Hanuihak Wonron. Seoul:Seongbosa. 2001:32-34.
20 Lesko LJ. Personalized medicine: elusive dream or imminent reality?. Clin Pharmacol Ther. 2007;81(6):807-16.   DOI
21 Schleidgen S, Klingler C, Bertram T, Rogowski WH, Marckmann G. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics. 2013;14:55.   DOI
22 Franzel B, Schwiegershausen M, Heusser P, Berger B. Individualised medicine from the perspectives of patients using complementary therapies: a meta-ethnography approach. BMC Complement Altern Med. 2013;13:124.   DOI
23 Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. CMAJ. 2000 Oct 3;163(7):837-41.
24 Tonelli MR. The philosophical limits of evidence-based medicine. Acad Med. 1998; 73(12):1234-40.   DOI
25 Goldman JJ, Shih TL. The limitations of evidence-based medicine--applying population-based recommendations to individual patients. Virtual Mentor. 2011;13(1):26-30.   DOI
26 Jain KK. Textbook of Personalized Medicine. New York:Springer. 2009:1-136.
27 Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticisms of Evidence-Based Medicine. Int J Med Inform. 2004;73(1):35-43.   DOI
28 Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;19(12): 491-6.   DOI   ScienceOn
29 Ray O. The revolutionary health science of psychoendoneuroimmunology: a new paradigm for understanding health and treating illness. Ann N Y Acad Sci. 2004;1032:35-51.   DOI
30 Yan Q. Toward the integration of personalized and systems medicine: challenges, opportunities and approaches. Personalized Medicine. 2011; 8(1):1-4.   DOI
31 Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, et al. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy. 2008;28(8):992-8.   DOI   ScienceOn
32 Novelli G. Personalized genomic medicine. Intern Emerg Med. 2010;5(1):81-90.
33 Lee SW, Lee KB, Kang JW, Choi JH, Oh JH. Trends in Personalized Medicine Research, Communications of the Korean Institute of Information Scientists and Engineer. 2011;29(4): 19-25.
34 Emilien G, Ponchon M, Caldas C, Isacson O, Maloteaux JM. Impact of genomics on drug discovery and clinical medicine. QJM. 2000; 93(7):391-423.   DOI